Skip to main content

Table 2 Reason for failure of antifungal prophylaxis with posaconazole oral suspension

From: Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study

 

PAP (n = 93)

SAP (n = 30)

P

Suspected IFD

11 (11.8)

6 (20.0)

0.259

Proven IFD

3 (3.2)

0 (0)

 

Probable IFD

5 (5.4)

3 (10)

 

Possible IFD

3 (3.2)

3 (10)

 

Gastrointestinal intolerance

20 (21.5)

5 (16.7)

0.567

Persistent fever

3 (3.2)

2 (6.7)

0.595

Drug–drug interaction

2 (2.2)

1 (3.3)

1.0

  1. PAP primary antifungal prophylaxis, SAP secondary antifungal prophylaxis, IFD Invasive fungal diseases. Suspected IFD: it includes proven/probable/possible IFDs.